Blue Note Therapeutics
Latest round
- Series A
Last raised
- Aug 2021
Total raised
- $15M
Investors
- 5
About Blue Note Therapeutics
Blue Note Therapeutics, Inc. focuses on creating evidence-based therapeutics for cancer patients. The company is headquartered in San Francisco, US. Geoffrey Eich serves as the CEO." The company provides a seamless transaction process, allowing clients to purchase or lease domain names essential for their online presence, particularly in the healthcare and wellness sectors.Blue Note Therapeutics generates revenue primarily from the sale and leasing of its domain names. Clients can purchase the domain outright for USD 4,911 or select a Lease to Own plan at USD 226 per month. This pricing model accommodates diverse client needs, including both direct consumers and businesses seeking a robust online identity.In August 2021, Blue Note Therapeutics, Inc. The funds will be utilized to expand their offerings and potentially enter new markets. The company plans to enhance its product line with upcoming evidence-based therapeutics, although specific release dates for new products have not been disclosed.
Who invested in Blue Note Therapeutics
5 investors across 2 rounds
See all investors in Blue Note Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Blue Note Therapeutics
Who invested in Blue Note Therapeutics?
Blue Note Therapeutics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Blue Note Therapeutics raised?
Blue Note Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Blue Note Therapeutics last raise money?
Blue Note Therapeutics's most recent round on record is a Series A, in Aug 2021.
What does Blue Note Therapeutics do?
Blue Note Therapeutics is a healthcare it company.
Where is Blue Note Therapeutics headquartered?
Blue Note Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like Blue Note Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Blue Note Therapeutics's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like Blue Note Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.